Title: Biotechnology in Taiwan
1Biotechnology in Taiwan
2Trends for Economic Development
- The Next Silicon Valley
- Battle for the Dot.Coms
- Biotech NBT (The Next Big Thing)
- 83 of local development agenciesplace bio among
their top two priorities - 41 countries have biotech development programs as
strategic priority
3Definition
- Biotechnology
- Firms using genetic and cellular techniques
- Biomedicine diagnostic/therapeutic
- Industry-developed definitions data
4Applications
- Agriculture
- Plant breeding to improve resistance to pests,
diseases, drought and salt conditions - Mass propagation of plant clones
- Bioinsecticide development modification of plants
to improve nutritional and processing
characteristics - Medicine
- Development of novel therapeutic molecules for
medical treatments - Diagnostics
- Drug delivery systems
- Tissue engineering of replacement organs
- Gene therapy
- Chemical Industry
- Production of bulk chemicals and solvents such as
ethanol, citric acid, acetone and butanol - Synthesis of fine specialty chemicals such as
enzymes, amino acids, alkaloids and antibiotics
5Applications
- Food Industry
- Production of bakers' yeast, cheese, yogurt and
fermented foods such as vinegar and soy sauce - Brewing and wine making
- Production of flavors and coloring agents
- Veterinary Practice
- Vaccine production
- Fertility control
- Livestock breeding
- Environment
- Biological recovery of heavy metals from mine
tailings and other industrial sources - Bioremediation of soil and water polluted with
toxic chemicals - Sewage and other organic waste treatment
6Products of Biotechnology
7Types of Industries
- Pharmaceuticals
- Very large, global firms
- Top ten average 15 billion sales
- Assets are products, distribution, manufacturing
expertise - Very Profitable
- Biotechnology
- Small, mostly single establishment firms
- Top ten average 700 million sales
- Principal assets are people, research and future
potential - Lose Money
8Experiences from USA Biotechnology Industry
- Biotech tends to cluster
- Leaders have an edge
- Entrepreneurship venture capital are key
- Outlook for biotech-led economic development
9Biotech tends to cluster
- Talent is drawn to where firms are firms form
where talent is - Powerful business advantages from agglomerations
- Lock-in to particular arrangements
10Leaders have an Edge
- Falling (further) behind the Leaders
- Biotech is concentrated and growing more so
- Leaders are
- 5 to 10x bigger than followers in research and
- 30 to 100x bigger than followers in
commercialization
11Keys for New Biotech
- Research base is necessary but not sufficient
- Commercialization Assets
- Entrepreneurial researchers
- Industry-relevant talent
- Technical
- Managerial
- Venture capital--surprisingly localized
12Competitiveness of Asia-Pacific Biotech
Note Survey was conducted by Asia-Pacific IMBN
Secretariat from August-December 1999. 20 leading
experts from around the region were invited to
share their perception of scientific development
in the region. The results are based on inputs
from 12 of these experts. Australia (3), Chinese
Taipei (1), Japan (3), Korea (1), Phlippines (3),
Singapore (1)
13Overview of Asia-PacificBiotech Ventures
Source BioEnterprise Asia, original research,
2001/2
Total Market Cap for about 1000 Asia-Pacific
Biotech Companies estimated to be about 3-5 of
Top 25 US Biotech Companies!
14- Singapore
- 700 million in investment funds
- Establish genome research center by recruiting
top-rank scientists - Taiwan
- 570 million in investment funds
- Japan
- 1,000 bioventure companies by 2010
15Evaluation of Asia Pacific Biotech Development
- Hurdles/Challenges
- Limited translation of academic research and
technology development into commercial
application - Lack of strategic and business management
expertise in life sciences - Lack of